ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO366

Diastolic Dysfunction Parameters in Patients with Intradialytic Hypertension

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Nguyen, Thuylinh M., The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Horvit, Andrew, The University of Texas Southwestern Medical Center, Dallas, Texas, United States
  • Van Buren, Peter N., The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Background

Hypertension and heart failure (HF) are common in hemodialysis (HD) patients, and intradialytic hypertension (IH) further increases mortality risk. We characterized differences in cardiac structure and function in patients with and without IH with a focus on the ratio of mitral inflow velocity (E) to mitral annular early diastolic velocity (e’).

Methods

We conducted a retrospective study of Dallas VA HD patients with available transthoracic echocardiograms (TTE). We calculated intradialytic blood pressure slope (IBPS) for each of 3 treatments before and after the TTE using all intradialytic measurements and defined IH as mean IBPS >0. We compared average E/e’ in patients with and without IH using Mann Whitney U (raw data) and unpaired t test (log transformed data). We used logistic regression with average E/e’ >14 as the primary outcome and IH as the primary predictor

Results

Average E/e’ was 17.1 (15-22) in the IH group (n=19) vs. 14.3 (10-18) in the non-IH group (n=37; p=.02). E/A was 1.18 (0.6) in IH vs. 0.95 (0.3) in non-IH (p=.06). IH patients had lower ejection fraction (EF) (p=.04) but higher left ventricular mass index (LVMI) (p=.007). While controlling for age, diabetes, race, and EF, IH predicted E/e’ >14 (OR 7.1 [1.6-44]); but this was blunted when controlling for LVMI (OR 3.1 [0.5-31)].

Conclusion

Diastolic dysfunction is common in HD patients and is more severe in IH. LVMI may mediate higher E/e’ in IH patients. TTE should be obtained in IH patients to better understand structural and functional abnormalities that may increase CV risk

Patient Characteristics
 No IH (N=37)IH (N=19)P- Value
Age (years)65.4 (9.4)68.1 (9.8)0.3
Diabetes29 (78%)10 (53%)0.07
Mean IBPS-3.48 (-6.1,-1.87)+1.11 (0.5-2.1)<0.0001
EF (Non-Teicholz) %55.6 (9.9)48.1 (17)0.04
Systolic Dysfunction7 (19%)9 (47%)0.03
Diastolic Dysfunction25 (89%)16 (100%)0.03
LVMI (N= 44;g/m2)108 (37)142 (40)0.007
E/A (n=53)0.95 (0.3)1.18 (0.6)0.06
Average E/e14.3 (9.9-18)17.1 (15-22)0.02

Funding

  • NIDDK Support